These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 22777090)

  • 21. Rapid spreading and immune evasion by vaccinia virus.
    Smith GL
    Adv Exp Med Biol; 2014; 808():65-76. PubMed ID: 24595611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses.
    Rojas JJ; Van Hoecke L; Conesa M; Bueno-Merino C; Del Canizo A; Riederer S; Barcia M; Brosinski K; Lehmann MH; Volz A; Saelens X; Sutter G
    Mol Ther; 2024 Jul; 32(7):2406-2422. PubMed ID: 38734899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design.
    Kaynarcalidan O; Moreno Mascaraque S; Drexler I
    Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in gene therapy using oncolytic vaccinia virus as vectors.
    Yang X; Huang B; Deng L; Hu Z
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2433-2440. PubMed ID: 30293118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinia virus vaccines: past, present and future.
    Jacobs BL; Langland JO; Kibler KV; Denzler KL; White SD; Holechek SA; Wong S; Huynh T; Baskin CR
    Antiviral Res; 2009 Oct; 84(1):1-13. PubMed ID: 19563829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication.
    Hagen CJ; Titong A; Sarnoski EA; Verardi PH
    Virus Res; 2014 Mar; 181():43-52. PubMed ID: 24394294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replication-inducible vaccinia virus vectors with enhanced safety in vivo.
    O'Connell CM; Jasperse B; Hagen CJ; Titong A; Verardi PH
    PLoS One; 2020; 15(4):e0230711. PubMed ID: 32240193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Research progress in the structure and fuction of Orthopoxvirus host range genes].
    Liu Z; Liu Y; Shao YM
    Bing Du Xue Bao; 2013 Jun; 29(4):437-41. PubMed ID: 23895011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery.
    Sutter G; Staib C
    Curr Drug Targets Infect Disord; 2003 Sep; 3(3):263-71. PubMed ID: 14529359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
    Sakhatskyy P; Wang S; Zhang C; Chou TH; Kishko M; Lu S
    Virology; 2008 Feb; 371(1):98-107. PubMed ID: 17950773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
    Taylor J; Paoletti E
    Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
    Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
    J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vector-based genetically modified vaccines: Exploiting Jenner's legacy.
    Ramezanpour B; Haan I; Osterhaus A; Claassen E
    Vaccine; 2016 Dec; 34(50):6436-6448. PubMed ID: 28029542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
    J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism.
    Pilna H; Hajkova V; Knitlova J; Liskova J; Elsterova J; Melkova Z
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.
    Vijaysri S; Jentarra G; Heck MC; Mercer AA; McInnes CJ; Jacobs BL
    Vaccine; 2008 Jan; 26(5):664-76. PubMed ID: 18096276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox Challenge.
    Noyce RS; Westfall LW; Fogarty S; Gilbert K; Mpanju O; Stillwell H; Esparza J; Daugherty B; Koide F; Evans DH; Lederman S
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.
    Volz A; Sutter G
    Adv Virus Res; 2017; 97():187-243. PubMed ID: 28057259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies.
    Volz A; Sutter G
    Vaccine; 2013 Sep; 31(39):4235-40. PubMed ID: 23523402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccinia virus-induced smallpox postvaccinal encephalitis in case of blood-brain barrier damage.
    Garcel A; Fauquette W; Dehouck MP; Crance JM; Favier AL
    Vaccine; 2012 Feb; 30(7):1397-405. PubMed ID: 22227123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.